Organization: Health Canada
Year: 2023
Month: March
Request Number: A-2022-001142
Request Summary: Adverse Drug Reaction (ADR) for VYVANSE. Report number: E2B_05734113. ADRs for C1 ESTERASE INHIBITOR (HUMAN). Report numbers: E2B_05727141, E2B_05795178, E2B_05743860, E2B_05760238. ADR for GAMMAGARD LIQUID. Report number: 001011695. ADRs for IMMUNOGLOBULIN (HUMAN). Report numbers: E2B_05726530, E2B_05792981, E2B_05726136, E2B_05747312.
Disposition: Disclosed in part
Number of pages: 128